HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma

Published:2019-12-14 Issue:6 Volume:476 Page:871-880
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Albrecht Thomas,Rausch Melina,Roessler Stephanie,Geissler Veronika,Albrecht Michael,Halske Christine,Seifert Carolin,Renner Marcus,Singer Stephan,Mehrabi Arianeb,Vogel Monika Nadja,Pathil-Warth Anita,Busch Elena,Köhler Bruno,Rupp Christian,Weiss Karl Heinz,Springfeld Christoph,Röcken Christoph,Schirmacher Peter,Goeppert Benjamin

Funder

Deutsche Forschungsgemeinschaft

The European Union's Horizon 2020 research and innovation programme

Wilhelm Sander-Stiftung

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00428-019-02706-6.pdf

Reference50 articles.

1. Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99–109. https://doi.org/10.2147/CLEP.S37357

2. Lai CH, Lau WY (2008) Gallbladder cancer--a comprehensive review. Surgeon 6:101–110

3. Villanueva L (2016) Cancer of the gallbladder-Chilean statistics. Ecancermedicalscience 10:704. https://doi.org/10.3332/ecancer.2016.704

4. Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC (2015) Gallbladder cancer incidence and mortality, United States 1999-2011. Cancer Epidemiol Biomark Prev 24:1319–1326. https://doi.org/10.1158/1055-9965.EPI-15-0199

5. Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4:695–706. https://doi.org/10.1038/nrc1429

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study;The Lancet Oncology;2023-07

2. A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers;Onco;2023-05-26

3. GBCdb: RNA expression landscapes and ncRNA–mRNA interactions in gallbladder carcinoma;BMC Bioinformatics;2023-01-09

4. Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma;Journal of Cancer Research and Therapeutics;2023

5. HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma;Frontiers in Genetics;2022-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3